Effect of temporin A modifications on its cytotoxicity and antimicrobial activity

APMIS

Volumn 113, Issue 7-8, 2005, Pages 497-505

  Mantyla T ^a   Sirola, H ^a   Kansanen, E ^a   Korjamo, T ^a   Lankinen, H ^b   Lappalainen, K ^c   Valimaa A L ^a   Harvima, I ^c   Närvänen, Ale ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antimicrobial peptide; Cytotoxicity; Keratinocyte; Temporin A

Indexed keywords

ANTIINFECTIVE AGENT; PEPTIDE DERIVATIVE; TAD; TAD L512; TAL L512; TEMPORIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL CULTURE; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CYTOTOXICITY; FROG; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DIMERIZATION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECIUM; HUMANS; KERATINOCYTES; PROTEINS; RANA TEMPORARIA; STAPHYLOCOCCUS AUREUS; STEREOISOMERISM;

EID: 23144440384     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2005.apm_107.x     Document Type: Article

References (28)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
2. Boman HG. Innate immunity and the normal microflora. Immunol Rev 2000;173:5-16.
3. Hancock REW, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother 1999;43:1317-23.
4. Hoffman JA, Kafatos FC, Janeway Jr CA, Ezekowitz RAB. Phylogenetic perspectives in innate immunity. Science 1999;284:1313-8.
5. Simmaco M, Mignogna G, Barra D. Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 1998;47:435-50.
6. Mangoni ML, Rinaldi AC, Giulio AD, Mignogna G, Bozzi A, Barra D, et al. Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur J Biochem 2000;267:1447-54.
7. Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur J Biochem 1996;242:788-92.
8. Harjunpää I, Kuusela P, Smoluch MT, Silberring J, Lankinen H, Wade D. Comparison of synthesis and antibacterial activity of temporin A. FEBS Lett 1999;449:187-90.
9. Wade D, Flock JI, Edlund C, Lofving-Arvholm I, Sallberg M, Bergman T, et al. Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide. Protein Pept Lett 2002;9:533-43.
10. Hujakka H, Ratilainen J, Korjamo T, Lankinen H, Kuusela P, Santa H, et al. Synthesis and antimicrobial activity of the dimeric form of Temporin A based on 3-N,N-di(3-aminopropyl)amino propanoic acid as the branching unit. Bioorg Med Chem 2001;9:1601-7.
11. Wade D, Silberring J, Soliymani R, Heikkinen S, Kilpeläinen I, Lankinen H, et al. Antibacterial activities of temporin A analogs. FEBS Lett 2000; 479:6-9.
12. Rinaldi AC, Mangoni ML, Rufo A, Luzi C, Barra D, Zhao H, et al. Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem J 2002;368:91-100.
13. Shai Y, Oren Z. From "carpet" mechanism to denovo designed diastereomeric cell selective antimicrobial peptides. Peptides 2001;22:1629-41.
14. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J 1999;341:501-13.
15. Rapaport D, Shai Y. Interaction of fluorescently labelled pardaxin and its analogues with lipid bilayers. J Biol Chem 1991;266:23769-75.
16. Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW. Membrane pores induced by magainin. Biochemistry 1996;35:13723-8.
17. Matsuzaki K. Why and how are peptide-lipid interactions utilized for delf-defence? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1999;1462:1-10.
18. Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labelled analogues with phospholipid membranes. Biochemistry 1992;31:12416-23.
19. Kragol G, Hoffmann R, Chattergoon MA, Lovas S, Cudic M, Bulet P, et al. Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. Eur J Biochem 2002;269:4226-37.
20. Levy SB. The future of antibiotics: facing antibiotic resistance. Clin Microbiol Infect 2000;6 Suppl 3:101-6.
21. Ghiselli R, Giacometti A, Cirioni O, Mocchegiani F, Orlando F, Kamysz W, et al. Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. J Vasc Surg 2002;36:1027-30.
22. Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Gov Y, Kamysz W, et al. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation. 2003;108:767-71.
23. Harvima IT, Virnes S, Kauppinen L, Huttunen M, Kivinen P, Niskanen L, et al. Cultured allogenic skin cells are effective in the treatment of chronic diabetic leg and foot ulcers. Acta Derm Venereol 1999;79:217-20.
24. Huttunen M, Hyttinen M, Nilsson G, Butterfield JH, Horsmanheimo M, Harvima IT. Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators. Exp Dermatol 2001;10:184-92.
25. van de Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RH, Langenhuijsen MM. Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study. J Immunol Methods 1991;141:15-22.
26. Otto W. Determination of cell number by DNA content. In: Leigh IM, Watt FM, editors. Keratinocyte Methods. Cambridge University Press: 1994:89-90.
27. Anderson R, Yu PL. Factors affecting the antimicrobial activity of ovine-derived cathelicidins against E. coli 0157:H7. Int J Antimicrob Agents 2005;25:205-10.
28. Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett 2001;501:146-50.